DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakene (Valproic Acid) - Sopor - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Sopor (26)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) where reactions include sopor. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18

Patient: female

Reactions: Intentional Overdose, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Borderline Personality Disorder

Depakene
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2012-07-06
    End date: 2012-07-06

Zolpidem Tartrate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-06
    End date: 2012-07-06

Abilify
    Administration route: Oral
    Indication: Borderline Personality Disorder

Abilify
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2012-07-06
    End date: 2012-07-06



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18

Patient: female

Reactions: Intentional Overdose, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abilify
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2012-07-06
    End date: 2012-07-06

Abilify
    Administration route: Oral
    Indication: Borderline Personality Disorder

Depakene
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2012-07-06
    End date: 2012-07-06

Depakene
    Administration route: Oral
    Indication: Borderline Personality Disorder

Zolpidem Tartrate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-06
    End date: 2012-07-06



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18

Patient: male

Reactions: Hypotension, Hypoglycaemia, Bradykinesia, Sopor, Bradyphrenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Lyrica
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Humalog
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Depakene
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Other drugs received by patient: Ramipril



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-09

Patient: male

Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Humalog
    Dosage: once
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Dosage: once
    Administration route: Oral
    Indication: Diabetic Neuropathy
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra
    Dosage: 100 iu/milliltre, 3 milliliters once
    Indication: Type 1 Diabetes Mellitus
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetime Hydrochloride
    Indication: Suicide Attempt

Optiset
    Dosage: 3 times a day, once
    Indication: Device Therapy
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetime Hydrochloride
    Dosage: once
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-23
    End date: 2012-05-23

Depakene
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Indication: Suicide Attempt

Apidra
    Indication: Suicide Attempt

Other drugs received by patient: Ramipril; Lantus



Possible Depakene side effects in 40 year old male

Reported by a physician from Italy on 2012-07-06

Patient: 40 year old male

Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Lyrica
    Dosage: dose:14 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Dosage: dose:56 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Depakene
    Dosage: dose:60 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Administration route: Oral

Duloxetine Hydrochloride
    Dosage: dose:56 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra Optiset
    Dosage: dose reported as 18iu, 26iu and 26iu

Optiset
    Indication: Device Therapy

Apidra Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Humalog
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Administration route: Oral

Apidra Optiset
    Dosage: dose reported as 18iu, 26iu and 26iu

Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Administration route: Oral

Lyrica
    Dosage: dose:14 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Administration route: Oral
    Indication: Diabetic Neuropathy

Other drugs received by patient: Ramipril; Lantus



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-18

Patient: male

Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Apidra
    Dosage: once
    Indication: Type 1 Diabetes Mellitus
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Dosage: once
    Administration route: Oral
    Indication: Diabetic Neuropathy
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra
    Indication: Suicide Attempt

Duloxetime Hydrochloride
    Dosage: once
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetime Hydrochloride
    Indication: Suicide Attempt

Depakene
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Humalog
    Dosage: once
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Optiset
    Dosage: 3 in 1 day, once
    Indication: Device Therapy
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Indication: Suicide Attempt

Other drugs received by patient: Ramipril; Lantus



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-15

Patient: male

Reactions: Hypokinesia, Intentional Overdose, Hypotension, Hypoglycaemia, Suicide Attempt, Sopor

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Apidra
    Dosage: once
    Indication: Type 1 Diabetes Mellitus
    Start date: 2012-05-23
    End date: 2012-05-23

Humalog
    Dosage: once
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra
    Indication: Suicide Attempt

Duloxetime Hydrochloride
    Dosage: once
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-23
    End date: 2012-05-23

Depakene
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetime Hydrochloride
    Indication: Suicide Attempt

Lyrica
    Dosage: once
    Administration route: Oral
    Indication: Diabetic Neuropathy
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Indication: Suicide Attempt

Optiset
    Dosage: 3 in 1 day, once
    Indication: Device Therapy
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Dosage: once
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-05-23
    End date: 2012-05-23

Other drugs received by patient: Ramipril



Possible Depakene side effects in 40 year old male

Reported by a physician from Italy on 2012-06-15

Patient: 40 year old male

Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Duloxetine Hydrochloride
    Administration route: Oral

Duloxetine Hydrochloride
    Dosage: dose:56 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Dosage: dose:14 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra Optiset
    Dosage: dose reported as 18iu, 26iu and 26iu

Apidra Optiset
    Dosage: dose reported as 18iu, 26iu and 26iu

Apidra Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Optiset
    Indication: Device Therapy

Duloxetine Hydrochloride
    Administration route: Oral

Lyrica
    Administration route: Oral

Depakene
    Dosage: dose:60 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Dosage: dose:56 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Dosage: dose:14 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Humalog
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Administration route: Oral
    Indication: Diabetic Neuropathy

Other drugs received by patient: Ramipril; Lantus



Possible Depakene side effects in 40 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13

Patient: 40 year old male

Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Humalog
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Dosage: dose:56 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Dosage: dose:56 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Valium
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Lyrica
    Dosage: dose:14 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra Optiset
    Dosage: dose reported as 18iu, 26iu and 26iu

Apidra Optiset
    Dosage: dose reported as 18iu, 26iu and 26iu

Duloxetine Hydrochloride
    Administration route: Oral

Lyrica
    Dosage: dose:14 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Tramadol HCL
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Apidra Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Optiset
    Indication: Device Therapy

Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Depakene
    Dosage: dose:60 unit(s)
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-05-23

Duloxetine Hydrochloride
    Administration route: Oral

Lyrica
    Administration route: Oral
    Indication: Diabetic Neuropathy

Lyrica
    Administration route: Oral

Apidra Optiset
    Start date: 2012-05-23
    End date: 2012-05-23

Other drugs received by patient: Ramipril



Possible Depakene side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-03

Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Confusional State, Multiple Drug Overdose Intentional, Self Injurious Behaviour, Sopor

Drug(s) suspected as cause:
Alprazolam
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Fluvoxamine Maleate
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-21
    End date: 2012-04-21

Risperidone
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21

Depakene
    Administration route: Oral
    Indication: Multiple Drug Overdose Intentional
    Start date: 2012-04-21
    End date: 2012-04-21



Possible Depakene side effects in 42 year old male

Reported by a physician from Italy on 2012-04-23

Patient: 42 year old male

Reactions: Multiple Drug Overdose Intentional, Self Injurious Behaviour, Sopor

Drug(s) suspected as cause:
Voltaren
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Ramipril
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Venlafaxine
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Aspirin
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Losartan Potassium
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Alcohol
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Mirtazapine
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Invega
    Administration route: Oral
    Start date: 2012-04-15
    End date: 2012-04-15

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Norvasc
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15

Depakene
    Administration route: Oral
    Indication: Self Injurious Behaviour
    Start date: 2012-04-15
    End date: 2012-04-15



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-09

Patient: male

Reactions: Hypotension, Multiple Drug Overdose Intentional, Sopor, Sinus Bradycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: gastro-resistant tablet, 1 in 1 d
    Administration route: Oral
    Indication: Borderline Personality Disorder

Zyprexa
    Dosage: coated, once
    Administration route: Oral
    Start date: 2011-01-30
    End date: 2011-01-30

Depakene
    Dosage: once, gastro-resistant tablet
    Administration route: Oral
    Start date: 2012-01-30
    End date: 2012-01-30

Zyprexa
    Dosage: coated
    Administration route: Oral
    Indication: Borderline Personality Disorder

Lorazepam
    Dosage: once
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2012-01-30
    End date: 2012-01-30

Other drugs received by patient: Diazepam



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-29

Patient: female

Reactions: Intentional Overdose, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Amisulpride; Zolpidem; Fluphenazine HCL; ALL Other Therapeutic Products; EN



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-16

Patient: female

Reactions: Intentional Overdose, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: EN; Amisulpride; Fluphenazine HCL; ALL Other Therapeutic Products; Zolpidem



Possible Depakene side effects in 81 year old male

Reported by a health professional (non-physician/pharmacist) from Austria on 2012-02-17

Patient: 81 year old male

Reactions: Dysphoria, Agitation, Sopor, Somnolence, Delirium

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Seroquel
    Dosage: 100 mg daily
    Administration route: Oral
    Start date: 2011-10-31
    End date: 2011-11-03

Lamictal
    Dosage: 300 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-01-01
    End date: 2011-11-05

Seroquel
    Dosage: 50 mg daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-01-01
    End date: 2011-10-31

Seroquel
    Dosage: 300 mg daily
    Administration route: Oral
    Start date: 2011-11-04
    End date: 2011-11-07

Seroquel
    Dosage: 150 mg daily
    Administration route: Oral
    Start date: 2011-10-31
    End date: 2011-11-03

Seroquel
    Dosage: 500 mg daily
    Administration route: Oral
    Start date: 2011-11-03
    End date: 2011-11-04

Lamictal
    Dosage: 100 mg daily
    Administration route: Oral
    Start date: 2011-11-05
    End date: 2011-11-07

Lorazepam
    Dosage: 3.75 mg daily
    Start date: 2011-11-07
    End date: 2011-11-30

Lithium Carbonate
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-01-01
    End date: 2011-11-07

Lorazepam
    Dosage: 4 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-03
    End date: 2011-11-07

Depakene
    Dosage: 800 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-02
    End date: 2011-11-04

Spironolactone
    Dosage: 25 mg daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-31
    End date: 2011-11-06

Other drugs received by patient: Digitoxin TAB; Marcoumar



Possible Depakene side effects in 21 year old female

Reported by a physician from Italy on 2012-02-15

Patient: 21 year old female

Reactions: Multiple Drug Overdose, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluoxetine
    Dosage: total: 360mg
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-01-09
    End date: 2012-01-09

Depakene
    Dosage: total: 4gm
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-01-09
    End date: 2012-01-09



Possible Depakene side effects in 21 year old female

Reported by a physician from Italy on 2012-02-08

Patient: 21 year old female

Reactions: Intentional Self-Injury, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: total: 4gm
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-01-09
    End date: 2012-01-09

Fluoxetine
    Dosage: total: 360mg
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2012-01-09
    End date: 2012-01-09



Possible Depakene side effects in 44 year old female

Reported by a physician from Italy on 2011-12-06

Patient: 44 year old female

Reactions: Vomiting, Multiple Drug Overdose Intentional, Sinus Tachycardia, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diazepam
    Dosage: .5 percent, 40 drops total
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2011-09-13
    End date: 2011-09-13

Diazepam
    Indication: Anxiety

Depakene
    Dosage: 20 unit (500 mg tablet) total
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2011-09-13
    End date: 2011-09-13

Depakene
    Indication: Schizoaffective Disorder

Nozinan
    Dosage: 20 unit (25 mg tablet)
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2011-09-13
    End date: 2011-09-13

Other drugs received by patient: Depakene; Alcohol



Possible Depakene side effects in 44 year old female

Reported by a physician from Italy on 2011-11-23

Patient: 44 year old female

Reactions: Vomiting, Multiple Drug Overdose Intentional, Sopor, Sinus Tachycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nozinan
    Dosage: 20 unit (25 mg tablet)
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2011-09-13
    End date: 2011-09-13

Diazepam
    Indication: Anxiety

Depakene
    Dosage: 20 unit (500 mg tablet) total
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2011-09-13
    End date: 2011-09-13

Depakene
    Indication: Schizoaffective Disorder

Diazepam
    Dosage: .5 percent, 40 drops total
    Administration route: Oral
    Indication: Intentional Overdose
    Start date: 2011-09-13
    End date: 2011-09-13

Other drugs received by patient: Depakene; Alcohol



Possible Depakene side effects in male

Reported by a physician from Italy on 2011-11-14

Patient: male

Reactions: Multiple Drug Overdose Intentional, Sopor, Bradyphrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Seroquel
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21

Diazepam
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21

Lendormin
    Administration route: Oral
    Indication: Depression
    Start date: 2011-06-21
    End date: 2011-06-21

Depakene
    Administration route: Oral
    Indication: Personality Disorder
    Start date: 2011-06-21
    End date: 2011-06-21

Depakene
    Administration route: Oral
    Start date: 2011-06-06
    End date: 2011-06-21

Lendormin
    Administration route: Oral
    Start date: 2011-06-06
    End date: 2011-06-21

Other drugs received by patient: Zoloft; Omeprazole; Lasix



Possible Depakene side effects in male

Reported by a physician from Italy on 2011-11-04

Patient: male

Reactions: Multiple Drug Overdose Intentional, Bradyphrenia, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lendormin
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21

Seroquel
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21

Depakene
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21

Diazepam
    Dosage: 0.5% drops oral solution 20 ml vial, used 200 mg once/single administration
    Administration route: Oral
    Start date: 2011-06-21
    End date: 2011-06-21



Possible Depakene side effects in 22 year old male

Reported by a physician from Croatia (Local Name: Hrvatska) on 2011-11-03

Patient: 22 year old male

Reactions: Intentional Overdose, Axillary Nerve Injury, Sopor, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Zoloft



Possible Depakene side effects in 22 year old male

Reported by a physician from Croatia (Local Name: Hrvatska) on 2011-10-28

Patient: 22 year old male

Reactions: Intentional Overdose, Axillary Nerve Injury, Asthenia, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Zoloft



Possible Depakene side effects in 24 year old female

Reported by a pharmacist from Italy on 2011-10-19

Patient: 24 year old female

Reactions: Intentional Overdose, Suicide Attempt, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 15 grams total
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2011-06-23
    End date: 2011-06-23

Acetaminophen
    Dosage: 5 mg total
    Administration route: Oral
    Indication: Intentional Self-Injury
    Start date: 2011-06-23
    End date: 2011-06-23



Possible Depakene side effects in 24 year old female

Reported by a pharmacist from Italy on 2011-10-09

Patient: 24 year old female

Reactions: Intentional Overdose, Suicide Attempt, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 5 mg total
    Administration route: Oral
    Indication: Intentional Self-Injury
    Start date: 2011-06-23
    End date: 2011-06-23

Depakene
    Dosage: 15 grams total
    Administration route: Oral
    Indication: Suicide Attempt
    Start date: 2011-06-23
    End date: 2011-06-23



Possible Depakene side effects in male

Reported by a physician from Italy on 2011-10-05

Patient: male

Reactions: Overdose, Heart Rate Decreased, Intentional Overdose, Bradycardia, Intentional Self-Injury, Sopor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
EN
    Indication: Intentional Self-Injury

EN
    Dosage: 20ml total, (prescribed 40 drops daily)
    Administration route: Oral
    Indication: Personality Disorder
    Start date: 2011-08-23
    End date: 2011-08-23

Depakene
    Dosage: 45 units total (prescribed 500mg 1 unit qd)
    Administration route: Oral
    Indication: Personality Disorder
    Start date: 2011-08-23
    End date: 2011-08-23

Depakene
    Indication: Intentional Self-Injury

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017